Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Intellect Neurosciences is a biotechnology company that focuses on discovery and development of neurodegenerative diseases. Read more

21 Followers on Owler
21 Followers on Owler
21 Followers on Owler
21 Followers on Owler

Intellect Neurosciences is a biotechnology company that focuses on discovery and development of neurodegenerative diseases. Read more

Elliot M. Maza's photo - Chairman & CEO of Intellect Neurosciences

Chairman & CEO

Elliot M. Maza

CEO Approval Rating

68/100

Founded:

2005

Status:

Out Of Business

SIC Code:

2834 NAICS listing »

Annual Revenue
Employees
Sector

Pharmaceuticals

Headquarters
Englewood Cliffs
New Jersey

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of Intellect Neurosciences?

I don't know

Quarterly and Annual Revenue

Coming soon for Intellect Neurosciences!

Annual Revenue

$10.8M

Acquisitions

No recent acquisitions found related to Intellect Neurosciences

Intellect Neurosciences Funding History

$450K$2.8M

Since Intellect Neurosciences was founded in 2005, it has participated in 2 rounds of funding. In total Intellect Neurosciences has raised $2.8M. Intellect Neurosciences' last funding round was on Apr 2010 for a total of $2.3M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Apr 2010
$2.3M
-
Debt
Aug 2009
$450K
-

Total Funding: $2.8M

Since Intellect Neurosciences was founded in 2005, it has participated in 2 rounds of funding. In total Intellect Neurosciences has raised $2.8M. Intellect Neurosciences' last funding round was on Apr 2010 for a total of $2.3M

Investments

No recent investments found related to Intellect Neurosciences

Intellect Neurosciences News

August 7, 2017BioPortfolio

Intellect Neurosciences Inc ILNS Financial and Strategic SWOT Analysis Review Report Updated 07082017 Prices from USD $300

SummaryIntellect Neurosciences Inc Intellect Neuro is a biopharmaceutical company that discovers and ... See more »
March 3, 2017BioPortfolio

Intellect Neurosciences Inc ILNS Financial and Strategic SWOT Analysis Review Updated 13012017 Prices from USD $300

SummaryIntellect Neurosciences Inc Intellect Neuro is a biopharmaceutical company that discovers and ... See more »
February 9, 2017BioPortfolio

Intellect Neurosciences Inc ILNS Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryIntellect Neurosciences Inc Intellect Neuro is a biopharmaceutical company that discovers and ... See more »
November 29, 2016BioPortfolio

Intellect Neurosciences Inc. formerly GlobePan Resources Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA Partnerships Alliances and Investments reports of... See more »
November 16, 2016BioPortfolio

Intellect Neurosciences Inc. ILNS Financial and Strategic SWOT Analysis Review Prices from USD $300

SummaryIntellect Neurosciences Inc. Intellect Neuro formerly GlobePan Resources Inc. is a biopharmace... See more »
May 8, 2016Equities

INTELLECT NEUROSCIENCES, INC. - 10-Q - MANAGEMENTS'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations contains i... See more »
January 7, 2016SYS-CON MEDIA

New Peer Reviewed Article Describes Role of TauC3 in AD Transgenic Mice

ENGLEWOOD CLIFFS, NJ--(Marketwired - January 07, 2016) - Intellect Neurosciences, Inc. (OTCQB: ILNS) ... See more »

Intellect Neurosciences Press Releases

June 4, 2015PR-INSIDE.COM

"Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis Review"

(PR-inside.com) Intellect Neurosciences, Inc. (Intellect Neuro) is a biopharmaceutical company. The c... See more »
May 2, 2015PR NEWSWIRE

Improved Diagnostics Fueling Interest of Companies in HD Research

DUBLIN, May 01, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/... See more »
April 15, 2015MARKETWIRED

Intellect Neurosciences Common Stock Approved for Trading on OTCQB

Company Initiates Collaboration With Harvard Medical School to Undertake Further Studies With TauC3 M... See more »
September 24, 2014GLOBENEWSWIRE

Intellect Neurosciences, Inc. Issues Letter to Shareholders

See more »
August 13, 2014GLOBENEWSWIRE

Intellect Neurosciences, Inc. Issues Letter to Shareholders

See more »
July 31, 2014GLOBENEWSWIRE

Intellect Neurosciences, Inc. Issues Letter to Shareholders

See more »

Social Media

Headquarters

550 Sylvan Ave

Englewood Cliffs, New Jersey07632

1-212-448-9300

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Intellect Neurosciences is a biotechnology company that focuses on discovery and development of neurodegenerative diseases. Intellect Neurosciences was founded in 2005. Intellect Neurosciences' headquarters is located in Englewood Cliffs, New Jersey, ...

CEO

Intellect Neurosciences's Chairman & CEO, Elliot M. Maza, currently has an approval rating of 68%. Intellect Neurosciences's primary competitors are

Website

intellectns.com

Frequently Asked Questions about Intellect Neurosciences

  1. When was Intellect Neurosciences founded?

    Intellect Neurosciences was founded in 2005

  2. Who is Intellect Neurosciences's CEO?

    Intellect Neurosciences's CEO is Elliot M. Maza

  3. How much revenue does Intellect Neurosciences generate?

    Intellect Neurosciences generates $10.8M in revenue

  4. How much funding does Intellect Neurosciences have?

    Intellect Neurosciences has historically raised $2.8M in funding

  1. Where is Intellect Neurosciences's headquarters?

    Intellect Neurosciences's headquarters is in Englewood Cliffs New Jersey, USA

  2. How many employees does Intellect Neurosciences have?

    Intellect Neurosciences has 38 employees

  3. What sector does Intellect Neurosciences operate in?

    Intellect Neurosciences is in Pharmaceuticals
Stay up-to-date with the latest news on Intellect Neurosciences

© 2021 Owler, Inc.